Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anthony T. Cacek"'
Publikováno v:
The Journal of Clinical Pharmacology. 57:247-254
The primary objective of the current investigation was to establish the pharmacokinetic characteristics of oxymetazoline and tetracaine's primary metabolite, para-butylaminobenzoic acid (PBBA), after the intranasal administration of oxymetazoline/tet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb56eeccd071e2c127083a62c76f9a6d
https://doi.org/10.1002/jcph.799
https://doi.org/10.1002/jcph.799
Publikováno v:
Journal of clinical pharmacology. 57(2)
The primary objective of the current investigation was to establish the pharmacokinetic characteristics of oxymetazoline and tetracaine's primary metabolite, para-butylaminobenzoic acid (PBBA), after the intranasal administration of oxymetazoline/tet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8b6eede2b2a2b03cca93fd2325b0664b
https://pubmed.ncbi.nlm.nih.gov/27436060
https://pubmed.ncbi.nlm.nih.gov/27436060
Autor:
Matthew Hutcheson, Helen Giannakopoulos, Stacey A. Secreto, Elliot V. Hersh, Anthony T. Cacek, Lawrence M. Levin, Joli C. Chou, Paul A. Moore
Publikováno v:
The Journal of the American Dental Association. 143:872-880
Background The authors evaluated the cardiovascular effects and pharmacokinetics of an intranasal 3 percent tetracaine/0.05 percent oxymetazoline spray developed to provide needle-free anesthesia of maxillary teeth. Methods The authors administered t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b5d20764497ffb9cb994f097a4a96c4
https://doi.org/10.14219/jada.archive.2012.0291
https://doi.org/10.14219/jada.archive.2012.0291
Autor:
Helen, Giannakopoulos, Lawrence M, Levin, Joli C, Chou, Anthony T, Cacek, Matthew, Hutcheson, Stacey A, Secreto, Paul A, Moore, Elliot V, Hersh
Publikováno v:
Journal of the American Dental Association (1939). 143(8)
The authors evaluated the cardiovascular effects and pharmacokinetics of an intranasal 3 percent tetracaine/0.05 percent oxymetazoline spray developed to provide needle-free anesthesia of maxillary teeth.The authors administered to 12 participants a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c5577a80b40603c74014b2891e22779f
https://pubmed.ncbi.nlm.nih.gov/22855901
https://pubmed.ncbi.nlm.nih.gov/22855901